Price T Rowe Associates Inc Mirum Pharmaceuticals, Inc. Transaction History

Price T Rowe Associates Inc

$812 Billion
Q1 2025

A detailed history of Price T Rowe Associates Inc transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 1,415,137 shares of MIRM stock, worth $64.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,415,137

Previous 1,422,729 0.53%

Holding current value

$64.1 Million

Previous $58.8 Million 8.37%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$41.32 - $53.16 $313,701 - $403,590	-7,592 Reduced 0.53%	1,415,137 $63.8 Million
Q4 2024 Feb 14, 2025	BUY	$37.85 - $46.65 $5.25 Million - $6.47 Million	138,623 Added 10.8%	1,422,729 $58.8 Million
Q3 2024 Nov 14, 2024	BUY	$33.68 - $44.74 $2.86 Million - $3.8 Million	84,886 Added 7.08%	1,284,106 $50.1 Million
Q2 2024 Aug 14, 2024	SELL	$23.57 - $34.85 $9.39 Million - $13.9 Million	-398,286 Reduced 24.93%	1,199,220 $41 Million
Q1 2024 May 15, 2024	BUY	$24.92 - $30.02 $10.8 Million - $13 Million	432,824 Added 37.16%	1,597,506 $40.1 Million
Q4 2023 Feb 14, 2024	BUY	$27.14 - $34.93 $30.7 Million - $39.6 Million	1,132,723 Added 3544.3%	1,164,682 $34.4 Million
Q3 2023 Nov 14, 2023	SELL	$24.63 - $32.85 $1.67 Million - $2.22 Million	-67,722 Reduced 67.94%	31,959 $1.01 Million
Q2 2023 Aug 14, 2023	BUY	$23.51 - $30.09 $2.06 Million - $2.64 Million	87,753 Added 735.69%	99,681 $2.58 Million
Q1 2023 May 15, 2023	SELL	$19.19 - $24.1 $94,088 - $118,162	-4,903 Reduced 29.13%	11,928 $287,000
Q4 2022 Feb 14, 2023	BUY	$17.59 - $23.83 $84,432 - $114,383	4,800 Added 39.9%	16,831 $328,000
Q3 2022 Nov 14, 2022	BUY	$19.98 - $29.44 $240,379 - $354,192	12,031 New	12,031 $253,000

Others Institutions Holding MIRM

# of Institutions

224

Shares Held

55.3M

Call Options Held

27.4K

Put Options Held

105K

View Full List

About Mirum Pharmaceuticals, Inc.

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.66B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

More about MIRM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Mirum Pharmaceuticals, Inc. Transaction History